IL22 Signaling in Epilepsy
癫痫中的 IL22 信号传导
基本信息
- 批准号:10548133
- 负责人:
- 金额:$ 40.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-15 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesAstrocytesAtopic DermatitisAttenuatedBiological ProductsBrainCell CommunicationCellsCharacteristicsClinical TrialsDNA Sequence AlterationDiseaseEncephalitisEpilepsyEpileptogenesisEtiologyGoalsHomeostasisHumanImmuneImmunohistochemistryImmunologicsIndividualInfectionInfiltrationInflammatoryInjectionsInjuryInterleukin-1 betaLeadLymphoid CellMacrophageMediatingMeningesMicrogliaModelingMusNeurologicNeuronal InjuryNeuronsPathologicPathologic ProcessesPeripheralPhase II Clinical TrialsPilocarpinePlayProcessProliferatingReactionRegulationReporterRoleSafetySignal TransductionStatus EpilepticusSurfaceSystemT-LymphocyteTNF geneTemporal Lobe EpilepsyTestingTranslatingUp-RegulationWestern Blottingastrogliosisbrain parenchymacombatcytokinedruggable targetglymphatic systemimmunoreactionimprovedinsightinterleukin-22mouse modelneuronal excitabilityneutralizing antibodynew therapeutic targetnovelpreclinical studypreventreceptorrecruitresponseresponse to injurytissue repair
项目摘要
Epileptogenesis is a pathological process that transforms a normal brain into an epileptic brain, typically
initiated by genetic mutations and neurological insults such as status epilepticus (SE). There is an unmet need
to understand epileptogenesis because it remains nearly unpreventable. Brain inflammation triggered by
neuronal injury is increasingly recognized as a contributor to epileptogenesis. Microglia, generally considered
as resident macrophages, are highly proliferated and activated in response to epileptogenic insults and thought
to play a primary role. Besides resident microglia, other immune cells in the peripheral system and CNS
lymphatic system also infiltrate the CNS compartment and likely contribute to epileptogenesis. It remains to be
understood how CNS resident and non-resident immune cells interact in response to epileptogenic insults and
how the injury-triggered changes in the immune network impinge on non-immune cells such as astrocytes and
neurons, thereby contributing to epileptogenesis. This proposal is built on our observation that IL22Rα1 is
strongly up-regulated in astrocytes in the pilocarpine model of temporal lobe epilepsy. This induction depends
on brain inflammation. Moreover, the induction of IL22Rα1 is critically involved in astrogliosis, an excessive
proliferation and activation of astrocytes frequently seen in epileptic brains. These findings lead to our central
hypothesis, that up-regulation of IL22/IL22Rα1 signaling promotes astrocyte proliferation, which in turn
contributes to epileptogenesis. Three specific aims are proposed to test our hypothesis. Aim 1 will determine
how IL22Rα1 expression is up-regulated in astrocytes. Aim 2 will elucidate how IL22-producing immune cells
are recruited into the CNS compartment. Aim 3 will determine if blocking IL22 signaling attenuates astrogliosis
and modifies the process of epileptogenesis. Our study will not only improve our understanding how IL22
signaling regulates epileptogenesis, but could also identify druggable targets to prevent epileptogenesis.
癫痫发生是一种病理过程,将正常大脑转化为癫痫大脑,通常是
由遗传突变和神经系统侮辱(例如癫痫症(SE))发起。有未满足的需求
了解癫痫发生,因为它几乎无法预防。脑部炎症触发
神经元损伤越来越多地被认为是癫痫发生的贡献者。小胶质细胞,通常考虑
由于居民巨噬细胞,对癫痫发作的响应高度增殖并激活
扮演主要角色。除居民小胶质细胞外,外周系统和中枢神经系统中的其他免疫细胞
淋巴系统还渗入中枢神经系统室,并可能有助于癫痫发生。还有
了解中枢神经系统居民和非居民免疫小球如何响应癫痫发作和
伤害触发了免疫网络中的变化,影响了星形胶质细胞等非免疫细胞的变化
神经元,从而导致癫痫发生。该提议建立在我们观察到IL22Rα1是
临时叶癫痫的毛果果模型中的星形胶质细胞中强烈上调。这种诱导取决于
关于脑注射。此外,IL22Rα1的诱导与星形胶质细胞增多症密切相关,过量
星形胶质细胞的增殖和激活经常在癫痫大脑中看到。这些发现导致了我们的中心
假设,IL22/IL22Rα1信号的上调促进了星形胶质细胞增殖
有助于癫痫发生。提出了三个特定目标来检验我们的假设。 AIM 1将确定
在星形胶质细胞中如何上调IL22Rα1的表达。 AIM 2将阐明如何产生IL22的免疫细胞
被招募到中枢神经系统车厢中。 AIM 3将确定阻塞IL22信号是否会减弱星形胶质细胞增多症
并修饰癫痫发生的过程。我们的研究不仅会改善我们的理解如何IL22
信号传导调节癫痫生成,但也可以鉴定可预防癫痫发生的可吸毒靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yunfei Huang其他文献
Yunfei Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yunfei Huang', 18)}}的其他基金
Understanding the role of microglia on epileptogenesis
了解小胶质细胞在癫痫发生中的作用
- 批准号:
8945775 - 财政年份:2015
- 资助金额:
$ 40.83万 - 项目类别:
Understanding the role of microglia on epileptogenesis
了解小胶质细胞在癫痫发生中的作用
- 批准号:
9310361 - 财政年份:2015
- 资助金额:
$ 40.83万 - 项目类别:
The mTOR pathway in neuronal death and epileptogenesis
mTOR 通路在神经元死亡和癫痫发生中的作用
- 批准号:
7693689 - 财政年份:2008
- 资助金额:
$ 40.83万 - 项目类别:
The mTOR pathway in neuronal death and epileptogenesis
mTOR 通路在神经元死亡和癫痫发生中的作用
- 批准号:
7583715 - 财政年份:2008
- 资助金额:
$ 40.83万 - 项目类别:
The mTOR pathway in neuronal death and epileptogenesis
mTOR 通路在神经元死亡和癫痫发生中的作用
- 批准号:
8133694 - 财政年份:2008
- 资助金额:
$ 40.83万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
$ 40.83万 - 项目类别:
Defining the autoimmune mechanisms driving human MOG antibody disease pathology
定义驱动人类 MOG 抗体疾病病理学的自身免疫机制
- 批准号:
10748070 - 财政年份:2023
- 资助金额:
$ 40.83万 - 项目类别:
Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease
发现针对大脑 TNF-α 的治疗性纳米抗体用于治疗阿尔茨海默病
- 批准号:
10697218 - 财政年份:2023
- 资助金额:
$ 40.83万 - 项目类别:
Role of Complement Receptor Activation in a Mixed Dementia Model
补体受体激活在混合痴呆模型中的作用
- 批准号:
10585080 - 财政年份:2023
- 资助金额:
$ 40.83万 - 项目类别: